NOTE 6. INVENTORIES

Inventories consist of finished goods, raw materials and work in process and are stated at the lower of cost or market and consist of the following (in thousands):

	September 30,		December 31,
	2015		2014

Raw materials	$	2,326	$	2,141
Work-in-process	1,119		1,348
Finished goods	7,909		4,967


Total	$	11,354	$	8,456

As of September 30, 2015, the unamortized portion of the step-up in fair value related to Nucynta® inventories acquired as part of the NUCYNTA Acquisition on April 2, 2015, was $0.1 million. The amount of the step-up in the fair value of NUCYNTA® inventories amortized to cost of sales during the three and nine months ended September 30, 2015 was $0.8 and $5.8 million respectively.

As of September 30, 2015 and December 31, 2014, the unamortized portion of the step-up in fair value related to Lazanda® inventories acquired as part of the Lazanda® Acquisition on July 29, 2013 was $0 and $0.2 million, respectively. The amount of the step-up in the fair value of Lazanda® inventories amortized to cost of sales during the three and nine months ended September 30, 2015 was $0 and $0.2 million, respectively.